PMID- 34432937 OWN - NLM STAT- MEDLINE DCOM- 20220314 LR - 20220314 IS - 1468-1293 (Electronic) IS - 1464-2662 (Linking) VI - 23 IP - 1 DP - 2022 Jan TI - Study of natural product adverse events in adult HIV-infected patients in Canada. PG - 29-38 LID - 10.1111/hiv.13155 [doi] AB - INTRODUCTION: Many individuals living with HIV use natural health products (NHPs) in an effort to decrease medication side effects and to enhance overall well-being. METHODS: An active surveillance study of adult patients (>/= 18 years) with HIV was conducted between 2012 and 2014 to detect prescription drug and NHP use and associated adverse events (AEs) in the last month. RESULTS: Of the 167 participants, 85 (50.9%) took prescription medications only, three (1.8%) took NHPs only, 75 (44.9%) took NHPs and prescription medications concurrently, and four (2.4%) took neither. Patients who used both prescription drugs and NHPs concurrently were more than three times more likely to experience an AE compared with those who used prescription drugs only (OR, P = 0.003, 95% CI: 1.47-6.91). CONCLUSIONS: Increased AEs are reported in patients with HIV who combine NHPs and prescription medications, and no serious AEs were reported. Active surveillance was found to be feasible in this clinical setting. CI - (c) 2021 British HIV Association. FAU - Sparks, Emma AU - Sparks E AD - Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. FAU - Zorzela, Liliane AU - Zorzela L AD - Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada. FAU - Necyk, Candace AU - Necyk C AD - Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada. FAU - Hughes, Christine AU - Hughes C AD - Department of Pediatrics, Medicine and Psychiatry, University of Alberta, Edmonton, Alberta, Canada. FAU - Vohra, Sunita AU - Vohra S AUID- ORCID: 0000-0002-6210-7933 AD - Department of Pediatrics, Medicine and Psychiatry, University of Alberta, Edmonton, Alberta, Canada. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20210825 PL - England TA - HIV Med JT - HIV medicine JID - 100897392 RN - 0 (Biological Products) RN - 0 (Prescription Drugs) SB - IM MH - Adult MH - *Biological Products/adverse effects MH - Canada/epidemiology MH - *Drug-Related Side Effects and Adverse Reactions/epidemiology MH - *HIV Infections/drug therapy MH - Humans MH - *Prescription Drugs OTO - NOTNLM OT - HIV OT - adverse events OT - antiretroviral OT - natural health products OT - pharmacovigilance EDAT- 2021/08/26 06:00 MHDA- 2022/03/15 06:00 CRDT- 2021/08/25 17:32 PHST- 2021/07/15 00:00 [received] PHST- 2021/07/23 00:00 [accepted] PHST- 2021/08/26 06:00 [pubmed] PHST- 2022/03/15 06:00 [medline] PHST- 2021/08/25 17:32 [entrez] AID - 10.1111/hiv.13155 [doi] PST - ppublish SO - HIV Med. 2022 Jan;23(1):29-38. doi: 10.1111/hiv.13155. Epub 2021 Aug 25.